Literature DB >> 10422851

Results of a population-based questionnaire on the symptoms and lifestyles associated with dry eye.

S Shimmura1, J Shimazaki, K Tsubota.   

Abstract

PURPOSE: This study was designed to assess public awareness and symptoms of dry eye in Japan by a population-based, self-diagnosis study.
METHODS: Two thousand five hundred participants chosen randomly from the general population were sent a questionnaire consisting of 30 questions pertaining to symptoms and knowledge of dry eye.
RESULTS: Awareness of the condition called "dry eye" was very high at 73%. Most of the knowledge of dry eye was obtained through the media (e.g., television, 58.8%; newspapers/magazines, 46.6%), and only a fraction of the knowledge was from physicians (6.8%). As many as 33% of participants responded that they believed they had dry eye according to the self-diagnosis criteria, of which 25% used over-the-counter eyedrops daily. The majority of eyedrop users were dissatisfied with their therapeutic effects, and only 11% sought professional help. Habits in lifestyles that were associated with self-diagnosed dry eye were contact lens use (p < 0.001), a history of allergic conjunctivitis (p = 0.002), and video display terminal tasks (p = 0.058).
CONCLUSION: Although public awareness of dry eye in Japan was high, only a minority of the population seems to consult professionals for diagnosis and symptomatic relief.

Entities:  

Mesh:

Year:  1999        PMID: 10422851     DOI: 10.1097/00003226-199907000-00003

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  37 in total

1.  Resolvin D1, but not resolvin E1, transactivates the epidermal growth factor receptor to increase intracellular calcium and glycoconjugate secretion in rat and human conjunctival goblet cells.

Authors:  Rebecca Kaye; Nora Botten; Marit Lippestad; Dayu Li; Robin R Hodges; Tor P Utheim; Charles N Serhan; Darlene A Dartt
Journal:  Exp Eye Res       Date:  2018-12-01       Impact factor: 3.467

2.  Characteristics of spontaneous eyeblink activity during video display terminal use in healthy volunteers.

Authors:  Nora Freudenthaler; Hartmut Neuf; Gregor Kadner; Torsten Schlote
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-10-25       Impact factor: 3.117

Review 3.  [Dry eye. An update on epidemiology, diagnosis, therapy and new concepts].

Authors:  F Schirra; K W Ruprecht
Journal:  Ophthalmologe       Date:  2004-01       Impact factor: 1.059

4.  Mesenchymal stem/stromal cells protect the ocular surface by suppressing inflammation in an experimental dry eye.

Authors:  Min Joung Lee; Ah Young Ko; Jung Hwa Ko; Hyun Ju Lee; Mee Kum Kim; Won Ryang Wee; Sang In Khwarg; Joo Youn Oh
Journal:  Mol Ther       Date:  2014-08-25       Impact factor: 11.454

Review 5.  Eye complaints in the office environment: precorneal tear film integrity influenced by eye blinking efficiency.

Authors:  P Wolkoff; J K Nøjgaard; P Troiano; B Piccoli
Journal:  Occup Environ Med       Date:  2005-01       Impact factor: 4.402

6.  Tear dysfunction and the cornea: LXVIII Edward Jackson Memorial Lecture.

Authors:  Stephen C Pflugfelder
Journal:  Am J Ophthalmol       Date:  2011-10-22       Impact factor: 5.258

Review 7.  [Blinking activity during visual display terminal work. Part 1: Ocular discomfort and pathophysiological principles].

Authors:  F Ziemssen; N Freudenthaler; K Regnery; T Schlote
Journal:  Ophthalmologe       Date:  2005-08       Impact factor: 1.059

8.  Dry Eye Disease: Impact on Quality of Life and Vision.

Authors:  Miki Uchino; Debra A Schaumberg
Journal:  Curr Ophthalmol Rep       Date:  2013-06

Review 9.  Prevalence and risk factors associated with dry eye symptoms: a population based study in Indonesia.

Authors:  A J Lee; J Lee; S-M Saw; G Gazzard; D Koh; D Widjaja; D T H Tan
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

10.  Etiology, prevalence, and treatment of dry eye disease.

Authors:  Johnny L Gayton
Journal:  Clin Ophthalmol       Date:  2009-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.